Trial intelligence / Profile preview

CoQ10 for postoperative cardiac events in vascular surgery

NCT03956017Phase 1Unknown

Start
Aug 2013
Primary completion
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in Myocardial injury comparing Ubiquinone with Placebo (2 arms). Primary endpoints: BNP levels following surgery at 48 hours, Cardiac Troponin levels following surgery at 48 hours and 2 more. Status: unknown.

02

Drugs

coenzyme q10
03

Conditions

Myocardial injury

Beyond the preview

Go deeper on NCT03956017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03956017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call